A 71-year-old woman with a 50-pack-year smoking history is referred to the oncology clinic after a routine chest radiograph reveals a 3.2-cm spiculated mass in the right upper lobe and a widened right paratracheal stripe. She has a chronic cough but is otherwise asymptomatic. Her performance status is excellent. Arrange the following steps in the most appropriate, evidence-based sequence for the diagnostic workup, clinical staging, and treatment planning of this patient's condition.
- 1Perform a contrast-enhanced computed tomography (CT) of the chest to anatomically characterize the mass and assess local extension.
- 2Obtain an 18F-FDG positron emission tomography (PET) scan to screen for distant metastases and identify metabolically active lymph nodes.
- 3Perform endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) to establish a tissue diagnosis and pathologically stage the mediastinum.
- 4Review the integrated clinical and pathological staging data at a multidisciplinary tumor board to evaluate surgical candidacy.
- 5Initiate definitive, stage-directed management, such as anatomical lung resection or definitive chemoradiotherapy.
Answer
The correct sequence for the evaluation and management of suspected non-small cell lung cancer is: CT chest for anatomical characterization, followed by a PET scan for metabolic staging, then EBUS-TBNA for tissue diagnosis and pathological nodal staging, followed by multidisciplinary review to determine surgical candidacy, and finally the initiation of stage-directed therapy.
The correct sequence for the evaluation and management of suspected non-small cell lung cancer ensures accurate staging while minimizing unnecessary procedures. Anatomical imaging (CT) characterizes the initial finding. Metabolic imaging (PET) provides whole-body clinical staging and guides the subsequent biopsy. Invasive tissue sampling (EBUS-TBNA) pathologically confirms the diagnosis and precise nodal status. A multidisciplinary tumor board then synthesizes this data to recommend the optimal stage-directed therapy, which is subsequently executed.
Step-by-Step Solution
Key Concept
The diagnostic algorithm for suspected lung cancer systematically progresses from noninvasive anatomical imaging (CT), to metabolic clinical staging (PET), to targeted invasive tissue sampling (EBUS-TBNA), ensuring accurate pathological staging prior to definitive multidisciplinary treatment decisions.